Dana Blankenhorn

Dana Blankenhorn

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

DWAC Stock Alert: Did Trump Just Kill the Truth Social Deal?

Trump's return to Twitter, now called X, after his Georgia arrest cast more doubt on the future of his Truth Social site, which Digital World wants to acquire in a SPAC merger.

Insider Richard Barry Just Doubled Down on Cassava (SAVA) Stock

Cassava is still enrolling patients in its Phase 3 study of the drug, which has a different target than Biogen's Leqembi.

Advanced Micro Devices Stock: The Bull Case vs. Bear Case

AMD will have a new 3 nanometer chip line in 2024, and remains competitive if second-best in both client and server markets.

APE Preferred Stock Falls as Conversion Date Looms

Some small investors are taking losses in AMC and APE stock while others prepare to take bigger losses as the Hollywood strikes continue.

Is It Too Late for Peloton (PTON) Stock?

Peloton is switching to a corporate marketing campaign after losing members and seeing sales fall after the COVID pandemic.

Novavax (NVAX) Stock Is Getting Ready to Rally Again

Novavax only has an Emergency Use Authorization and faces a struggle to get paid for its protein-based Covid shot.

Ignore the Post-Earnings Retreat and Keep Betting on SOFI Stock

SoFi's earnings ratified its business model. Events since should help it transition into a leading fintech and software supplier.

NKLA Stock Alert: Nikola Plunges on New Note Offering

Nikola wants to raise $325 million from NKLA stock investors as it fights to save its electric and hydrogen truck strategies.

Antara Capital Slashes Its Stake in AMC Entertainment (APE) Stock

If big investors in distressed assets like Antara are leaving APE stock, it could spell trouble for small investors who stay in.

LI Stock Forecast: Why the Future Looks Electric for Li Auto, Despite Political Storms

Li Auto makes cars the world wants and needs. But it's increasingly difficult to justify any investment in Xi Jinping's China.